The concurrent specific deletion of p53 and Pten in central nervous system of mice could lead to high-grade malignant glioma phenotypes which closely resemble human primary GBM in clinical, pathology, and molecular characteristics (Zheng et al., 2008). Here, PTEN is linked to central nervous system cancer.